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ABSTRACT
Arterial oxygen saturation has not been assessed
sequentially in conscious mice as a direct consequence
of an in vivo murine model of acute lung injury. Here,
we report daily changes in arterial oxygen saturation
and other cardiopulmonary parameters by using
infrared pulse oximetry following intratracheal
lipopolysaccharide (IT-LPS) for up to 9 days, and
following IT-phosphate buffered saline up to 72 h as a
control. We show that arterial oxygen saturation
decreases, with maximal decline at 96 h post IT-LPS.
Blood oxygen levels negatively correlate with 7 of 10
quantitative markers of murine lung injury, including
neutrophilia and interleukin-6 expression. This
identifies infrared pulse oximetry as a method to non-
invasively monitor arterial oxygen saturation following
direct LPS instillations.
INTRODUCTION
Acute lung injury (ALI) and its most severe
form, acute respiratory distress syndrome
(ARDS), are deﬁned in patients by acute
onset, bilateral pulmonary inﬁltrations
(reﬂecting pulmonary oedema) and hypoxe-
mic respiratory failure (P : F ratio less than
300 mm (40 in SI units).1–3 Animal models
are used to replicate pathological, physio-
logical and histological changes in human
ALI/ARDS.4
Lipopolysaccharide (LPS) is a potent activa-
tor of the innate immune system via toll-like
receptor 4 pathways.5 Intratracheal (IT) LPS
is a very reproducible technique which
models many of the features in human ALI,
typiﬁed by signiﬁcant inﬁltration of neutro-
phils into the alveolar air spaces and expres-
sion of pulmonary inﬂammatory cytokines.6–8
Neutrophil accumulation post IT-LPS is fol-
lowed by initiation of active resolution path-
ways which are required to inhibit neutrophil
recruitment, and induce cell death and
clearance.
The determination of murine lung injury fol-
lowing LPS typically involves assessment of cel-
lular and cytokine responses which are
correlated with markers of lung injury.
Bronchoalveolar lavage (BAL) markers
common to human and rodent lung injury
include the protein permeability index (PPI;
ratio of lung lavage ﬂuid : plasma or serum
protein levels) and the receptor for advanced
glycation end products (RAGE).9 10 BAL PPI
and RAGE have been extensively used both in
translational/murine studies as soluble markers
of alveolar epithelial damage. However, in
murine lung injury models repeated lung
lavage is not practically feasible or ethically
acceptable (in the UK). There is therefore a
need for a non-invasive marker of lung damage
that can be assessed sequentially in mice.
Pulse oximetry is widely used as an assess-
ment tool for humans with acute and chronic
respiratory conditions. The technical chal-
lenges of pulse oximetry in mice are high due
to low pulse volume and very high heart rates.
Recent advances in probe design and software
analysis now make oximetry feasible as a non-
invasive assessment of lung damage in murine
models of lung injury. Pulse oximetry in
murine studies is therefore increasingly
popular as a technique to monitor the level of
oxygen carried on arterial haemoglobin in
conscious mice, without the use of surgery.11–13
In this study we used a pulse oximetry
system to monitor lung function daily in a
murine model of ALI. Our aims were ﬁrst, to
measure pulse oximetry in mice over the
course of the inﬂammatory response follow-
ing IT-LPS or phosphate buffered saline
(PBS) as a control, and second, to compare
oximetry readings to multiple lung injury
KEY MESSAGES
▸ IT-LPS in mice causes a significant reduction in
arterial oxygen saturation.
▸ Arterial oxygen saturation negatively correlates
to markers of lung injury.
▸ Pulse oximetry can be used to define markers of
injury that affect lung function.
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and inﬂammation markers including PPI, RAGE, pul-
monary neutrophils and local cytokine expression.
MATERIALS AND METHODS
Mice and IT instillations
Male 9–12-week-old wild type (WT) C57Bl/6 mice, with
an average body weight of 25 g (±0.7 g) were obtained
from Harlan UK Limited, Oxford, UK and maintained at
BMSU, Birmingham University, UK. All experiments
were performed in accordance with UK laws with
approval of local ethics committees. IT instillations were
performed as previously described.14 Brieﬂy, mice were
anaesthetised using intraperitoneal injections of meteto-
midine (60 mg/kg) and ketamine (10 mg/kg) and a ﬁne
polyethylene catheter (external diameter 0.61 mm and
internal diameter 0.28 mm) passed into the trachea via
the mouth under direct visualisation of the vocal cords.
Fifty micrograms LPS (Source Biosciences, UK) in 50 µL
sterile PBS or PBS alone were instilled. Mice were given
0.1 mL atipamezole to reverse the metetomidine and
hydrated with two 0.5 mL saline subcutaneous injections,
one immediately post IT and another 6 h later.
Infrared pulse oximetry
Following IT instillations, the hair around the neck of
each mouse was removed using Veet (Unilever, UK).
Twenty-four hours post IT instillation and then every 24 h
after that cardiopulmonary health status of each mouse
was measured by MouseOx Plus (Starr Life Sciences
Corp, USA) in accordance with manufacturer’s instruc-
tions, up to and including 96 h (day 4) and also on day
9. Each mouse was very brieﬂy anaesthetised using 5%
isoﬂurane to facilitate placement of a CollarClip Sensor
and allowed to acclimatise for 5 min. This time point was
sufﬁcient for animals to recover normal activities and
physiological readings. Measurements were then
recorded for 10 min. This time point was used to collect
representative, error-free data due to the motion arte-
fact.15 This was averaged for all parameters.
Assessment of BAL fluid cellular and inflammatory
markers
Mice were sacriﬁced by exsanguination, serum collected
and BAL performed with two washes of 0.6 mL PBS/
EDTA (2 mM). BAL ﬂuid was centrifuged at 400 g at 4°
C with supernatant aliquoted and either used directly or
stored at −20°C for analysis of cellular and inﬂammatory
markers. Markers of oedema and endothelial damage—
PPI (BioRad protein assay)—epithelial damage—BAL
RAGE (DuoSet ELISA, R&D systems, UK)—and inﬂam-
mation—proinﬂammatory cytokines interleukin (IL)-6,
IL-1β and tumor necrosis factors α (TNFα), neutrophil
chemokines CXCL1/KC and macrophage-inﬂammatory
protein-2 (MIP-2), and the epithelial repair growth
factor vascular endothelial growth factor (VEGF;
Fluorokine MAP Multiplex, R&D systems, UK)—were
measured. These parameters were chosen because they
are all well-characterised, quantitative markers of
damage and inﬂammation used in several murine
models of ALI/ARDS. The remaining cell pellets were
analysed directly by ﬂow cytometry.
Flow cytometry
Cells pelleted from BAL ﬂuid were assessed for neutro-
phil inﬂammation by ﬂow cytometry using ﬂuorophore-
conjugated antibodies (eBioscience). Granulocytes were
enumerated by gating on cells with a high forward and a
high side scatter distribution. Neutrophils were deﬁned
as CD11c negative, CD11b+Gr1hiF4/80− granulocytes.
All ﬂow cytometry data are presented per mL of BAL.
Statistical analysis
All parameters were analysed using Prism 6 (GraphPad
Software Inc, USA). Data were tested for normality and
signiﬁcance assessed by an ordinary one-way analysis of
variance. Two-tailed Student t tests were also used as
indicated in the text. Linear regression was calculated by
two-tailed Pearson correlations. All data are expressed as
the mean of three experiments, each with at least three
mice/time point (±SE of the mean).
RESULTS
IT-LPS but not PBS causes a significant decline
in lung function
Following IT-LPS, the general health status of the mice
was assessed daily by measuring weight loss of the
animals. By 96 h (day 4) post-IT instillation, the mice
started to gain weight indicating an improvement in
health status (ﬁgure 1A). To control for the effects oper-
ation and LPS challenge a separate group of mice were
instilled with PBS via IT injection. Weight loss was only
observed 24 h post IT-PBS, which is likely due to the use
of intraperitoneal anaesthetic which reduces the
mouse’s water and food intake within the ﬁrst 24 h
(ﬁgure 1B). To monitor the physiological consequence
of causing ALI in mice we used infrared pulse oximetry
on conscious, non-anaesthetised, mice. In mice given
PBS instillation arterial oxygen saturation (SaO2;
p=0.9621), heart rate (p=0.7025) and breath rate
(p=0.9875) did not signiﬁcantly alter during 72 h post
IT. A reduction in SaO2 was observed from 48 h post
IT-LPS (ﬁgure 1C). By 96 h post IT-LPS, mean saturation
had reduced further to 81.1% (±1.6%). Oxygen satur-
ation normalised by day 9, conﬁrming that
IT-LPS-dependent lung injury causes a signiﬁcant but
recoverable decline in lung function. In contrast, breath
rate dropped only at 24 h post IT-LPS and then returned
to levels similar to PBS controls (ﬁgure 1D). This
cardiac suppression observed at 24 h post IT-LPS has
been appreciated for LPS-based mouse models previ-
ously.16 Breath rate of LPS-treated mice did not alter sig-
niﬁcantly during the time course (p=0.0926; ﬁgure 1E).
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IT-LPS results in significant cellular inflammation and
local cytokine release
We analysed lung damage, cellular inﬁltration and
inﬂammatory cytokine responses of WT mice to IT-LPS
every day for 4 days and at 9 days post IT-LPS. IT-LPS
caused signiﬁcant lung injury as assessed by PPI and
alveolar epithelial cell damage (BAL RAGE expression;
ﬁgure 2A,B, respectively). Both parameters peaked at
72 h post IT-LPS from which they decreased. PPI levels
at day 9 post IT-LPS remained signiﬁcantly higher com-
pared to preinstillation controls (0.0024±0.0002 vs
0.0047±0.0009, p=0.0030).
IT-LPS results in signiﬁcant pulmonary granulocyte
inﬁltration 24 h post IT-LPS which peaked at 48 h
(ﬁgure 2C). As expected, cellular inﬁltration consisted
primarily of neutrophils, with percentage peaking 24 h
post IT-LPS (ﬁgure 2D). Although the numbers of BAL
neutrophils are signiﬁcantly reduced by 96 h post IT,
BAL neutrophilia remained signiﬁcantly elevated 9 days
post LPS compared to resting levels (109±50 vs 1994
±764, p=0.0009; ﬁgure 2E).
Expression of well-characterised inﬂammatory cytokines
and chemokines was also analysed. Levels in BAL ﬂuid
peaked at either 24 h (CXCL1/KC, VEGF and MIP-2) or
48 h (IL-6, IL-1β and TNFα) post IT-LPS (ﬁgure 3A–F).
Some subtle differences were observed during resolution;
while CXCL1/KC, IL-1β and TNFα expression resolved by
96 h (with measured levels below the sensitivity of the
assay), MIP-2 and IL-6 remained elevated (20.1 and
127.3 pg/mL, respectively) at 96 h and only by 9 days
post IT-LPS did levels return to those of resting mice
(ﬁgure 3C,D, respectively). Moreover, while VEGF
resolved to pre-IT-LPS levels by around 72 h post IT-LPS
(261.0±12.0 pg/mL), expression continued to fall below
those of resting mice at 96 h (79.8±22.4 pg/mL, p<0.0001)
and by day 9 levels still remained lower than those
observed pre-IT instillations (151.3±32.0 pg/mL,
p=0.0083; ﬁgure 3B). These changes in VEGF reﬂect the
Figure 1 Weight and cardiopulmonary parameter changes in C57Bl/6 mice post IT-LPS or PBS. Weight changes were
assessed in C57Bl/6 instilled via IT route with 50 µg LPS (A) or 50 µL PBS (B). Arterial oxygen saturation (C), heart rate (D) and
breath rate (E) were monitored using infrared pulse oximetry following IT-PBS as a control (white bars) compared to IT-LPS
instilled mice (black bars). IT-LPS, intratracheal lipopolysaccharide; PBS, phosphate buffered saline.
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pattern, albeit with a different time course, seen in human
ALI and have not been reported previously.
IT-PBS induces mild cellular inflammation without
affecting lung permeability
As a control, a second group of mice were instilled with
IT-PBS and indexes of pulmonary damage, cellular inﬁl-
tration and cytokine expression measured for 3 days. No
signiﬁcant changes in PPI or RAGE expression were
observed at all time points measured following IT-PBS
(data not shown). A small but signiﬁcant granulocytic
inﬁltration was observed 24 h post IT-PBS which resolved
within 72 h (ﬁgure 4A). Cellular inﬁltrates contained
neutrophils, however, these were at a much lower pro-
portion than IT-LPS instilled mice (ﬁgure 4B,C).
Consistent with no epithelial cell damage, expression of
inﬂammatory cytokines was not observed above the
detection threshold of the assays performed again valid-
ating the use of PBS as a non-inﬂammatory control
substance (data not shown).
SaO2 correlates to indices of lung injury
Having shown that cardiopulmonary parameters can be
measured to assess lung function following IT-LPS we
investigated how these parameters relate to quantitative
markers of lung inﬂammation and damage. Table 1 dis-
plays the R2 value and p value of each cardiopulmonary
parameter correlated to the lung injury, inﬂammatory cell
recruitment and cytokine expression data—signiﬁcant
Figure 2 Markers of lung injury in C57Bl/6 mice post IT-LPS. C57Bl/6 mice were instilled via IT route with 50 µg LPS. Markers
of endothelial barrier permeability (A) and alveolar epithelial cell damage by assessing RAGE expression (B) were assessed
daily. The total number of granulocytes in BAL fluid was also enumerated per mL (C). The percentage (D) and number (E) of
neutrophils were analysed using flow cytometry. ANOVA, analysis of variance; BAL, bronchoalveolar lavage; IT-LPS, intratracheal
lipopolysaccharide; RAGE, receptor for advanced glycation end.
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data are highlighted in bold. SaO2 negatively correlates
with most inﬂammation markers measured (7 of 10).
DISCUSSION
Recent studies have used the MouseOx Plus for a variety
of reasons including demonstration of hypoxaemia in
transgenic mouse models,17 differential SaO2 following
mechanical ventilation18 and monitoring of oxygen sat-
uration post toxic gas inhalation.19 However, to date, no
study has used this system to monitor arterial blood
oxygen saturation following IT instillations of LPS, a
well-characterised model of ALI/ARDS. This study
demonstrated that infrared pulse oximetry can monitor
the decline in SaO2 following IT-LPS and highlights for
the ﬁrst time the effect of cumulative neutrophil recruit-
ment over several days, which results in oxygen satur-
ation to decrease to 81.1%. A surprising result was that
the lowest SaO2 levels were observed 96 h post IT-LPS
instillation, a time point when markers of pulmonary
injury and inﬂammation were returning to normal. This
lag in lung function decline has not been appreciated
before but implies that resolution of lung injury worsens
oxygenation in mice. The mechanisms for this change
Figure 3 Pulmonary cytokine expression in C57Bl/6 mice post IT-LPS. C57Bl/6 mice were instilled via IT route with 50 µg LPS.
BAL fluid was collected daily following IT-LPS and the expression of inflammatory cytokines assessed; CXCL1/KC (A), VEGF
(B), MIP-2 (C), IL-6 (D), IL-1β (E) and TNFα (F). ANOVA, analysis of variance; BAL, bronchoalveolar lavage; IL, interleukin;
IT-LPS, intratracheal lipopolysaccharide; MIP-2, macrophage-inflammatory protein-2; N.D., not detected; TNFα, tumor necrosis
factors α; VEGF, vascular endothelial growth factor.
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are uncertain but may relate to restoration of blood ﬂow
to damaged areas of lung resulting in increased
ventilation-perfusion mismatch.
An important ﬁnding of this study is that SaO2 corre-
lates with well-characterised markers of pulmonary
injury and inﬂammation used to assess the extent of
ALI/ARDS in mice following IT-LPS. Indeed, SaO2 was
the only cardiopulmonary parameter measured by the
MouseOX Plus that correlated with the speciﬁc marker
of alveolar epithelial cell damage, BAL RAGE expres-
sion. This may suggest that blood oxygen levels can be
used in future experiments to verify whether quantitative
Figure 4 Granulocytic pulmonary infiltrates in C57Bl/6 mice post IT-PBS. C57Bl/6 mice were instilled via IT route with 50 µL
PBS. BAL fluid was collected daily and pulmonary granulocytic infiltrates (A) and neutrophilia (B and C) assessed. ANOVA,
analysis of variance; BAL, bronchoalveolar lavage; IT, intratracheal; PBS, phosphate buffered saline.
Table 1 Correlations of markers of lung injury and inflammation, with cardiopulmonary parameters measured in C57Bl/6
mice post IT-LPS and PBS
Lung injury marker
Arterial oxygen
saturation Breath rate Heart rate
R2 p Value R2 p Value R2 p Value
Permeability index −0.154 0.0122 −0.075 0.0916 −0.291 0.0004
RAGE expression −0.219 0.0282 −0.002 0.8247 −0.077 0.1619
Granulocyte count −0.108 0.0408 0.044 0.1792 −0.136 0.0150
Neutrophil count −0.193 0.0073 0.039 0.2129 −0.094 0.0484
CXCL1/KC −0.014 0.5118 0.042 0.2427 −0.019 0.4335
IL-6 −0.411 <0.0001 0.137 0.0285 −0.049 0.2013
MIP-2 0.036 0.2972 0.133 0.0405 <0.001 0.9737
TNFα −0.285 0.0014 0.060 0.1696 −0.021 0.4167
VEGF −0.065 0.1516 <−0.001 0.9176 −0.315 0.0005
IL-1β −0.280 0.0165 0.068 0.2662 <−0.001 0.9972
Significance and R2 values were calculated using a two-tailed Pearson correlation.
IL, interleukin; IT-LPS, intratracheal lipopolysaccharide; LPS; MIP-2, macrophage-inflammatory protein-2; PBS, phosphate buffered saline;
RAGE, receptor for advanced glycation end; TNF α, tumor necrosis factors α; VEGF, vascular endothelial growth factor.
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lung injury markers directly affect lung function.
However, a limitation of this study is that arterial blood
samples were not analysed directly, in tandem to pulse
oximetry to corroborate SaO2 readings. Changes in
arterial PO2 have been shown recently to correlate to
SaO2.
18 In addition, our data suggest that SaO2 readings
continue to drop from 48 to 96 h after IT-LPS even
though heart and breath rate remain unchanged at
these time points (ﬁgure 1C–E). Taken together these
data suggest that SaO2 monitored during this study is
reﬂective of the relative oxygen saturation within the
artery.
Our data also suggest that RAGE expression increased
24 h post IT-LPS even though systemic hypoxaemia as
determined by SaO2 was unchanged compared to
PBS-treated controls. Previous in vitro experiments have
suggested that RAGE expression is regulated by hypoxia
by HIF1α,20 although to date type 1 lung epithelial cells
have not been tested. Therefore, these data may reﬂect
hypoxia-independent enzymatic cleavage and/or
cytokine-induced RAGE release from epithelial cells or
simply an effect of local tissue hypoxia prior to systemic
hypoxemia.
Refractory expression of BAL VEGF was observed
during the latter stages of lung repair following IT instil-
lation of LPS. VEGF is predominantly expressed by
alveolar type II cells in the lung,21 with contributions
from macrophages and neutrophils during inﬂammatory
responses.22 In this context, the role of VEGF in the
lung is as a potent stimulus for endothelial and epithe-
lial repair.23 24 The decrease in VEGF observed from
96 h in this model closely resembles the reduced VEGF
levels observed in patients with ALI, which may be asso-
ciated with impaired repair responses or reﬂect speciﬁc
loss of alveolar type II cells following injury.25 Decline in
lung function was also maximal at 96 h. This may
suggest that future experiments using murine IT-LPS as
a model of ALI should monitor this time point in par-
ticular. Although we did not extend our time points
further than 9 days, it would be interesting in future
studies to focus on this phase given that in addition to
reduced VEGF levels, BAL neutrophilia and PPI
remained elevated compared to resting levels at day 9
post IT-LPS. This was observed even though the levels of
inﬂammatory chemokines associated with leucocyte
chemotaxis such as CXCL1/KC and MIP-2 had returned
to pre-IT-LPS levels. Taken together, these data are sug-
gestive of permanent damage to alveolar-capillary bar-
riers as a result of IT-LPS. A similar observation can be
seen in other experimental models of inﬂammation
when tissue function recovers but restoration of leuco-
cyte populations do not return to predisease levels.26
Using pulse oximetry, we found the heart rate of our
mice to average around 650–700 bpm (ﬁgure 1D). This
mirrors recently published data which also used the
MouseOx Plus system.27 However, resting mice have
been previously shown to average 400–600 bpm.28 29
Heart rates of this magnitude were most similar to those
of mice 24 h post IT-LPS. The MouseOx Plus system we
used involved collar clips being placed directly on the
animal and allowing them to wander freely in a cage.
Therefore, we would suggest this to be a more sensitive
reading of cardiac output than older technologies.
As a consequence of lung injury, direct readings
obtained by the MouseOx Plus system became easier to
monitor (more error-free data points) mainly due to the
reduction in the mouse’s activity. At extended time
points, such as day 9, readings were more challenging
not only due to the increased activity of the subject, but
also due to regrowth of the hair around the neck and
shoulders which can retard the infrared signals. These
issues should be considered in future experiments using
the MouseOx Plus system.
In conclusion, this study is the ﬁrst to measure mul-
tiple quantitative markers of lung injury and inﬂamma-
tion alongside non-invasive monitoring of
cardiopulmonary parameters during a mouse model of
ALI. Our data revealed that lung function decline is
maximal at 96 h post IT-LPS and that well-characterised
indices of lung injury and inﬂammation correlate with
SaO2. Pulse oximetry readings are easy to measure, and
can be carried out with minimal stress to the animal,
providing real-time data indicative of lung function as
assessed by SaO2. Therefore this parameter may have
the potential to predict outcome, help ensure humane
endpoints are maintained and reduce animal usage by
identifying points at which lung function differs from
expected results.
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